Edwards Lifesciences Corp. (NYSE: EW) reported Q4 EPS of $0.62, $0.03 better than the analyst estimate of $0.59. Revenue for the quarter came in at $430.2 million versus the consensus estimate of $446.94 million.

For earnings history and earnings-related data on Edwards Lifesciences Corp. (EW) click here.

Earnings